On Aug. 7, 2026, The Centers for Disease Control and Prevention (CDC) confirmed 94 new measles infections—most of…
On Jul. 24, 2026, the number of measles cases in the U.S. surpassed the record-breaking tally for all…
On Jun. 16, 2025, the National Institute for Health and Care Excellence (NICE) announced that the recommendation in…
On Sept. 16, 2022, Novavax announced that the Taiwan Food and Drug Administration had granted expanded emergency use…
On Sept. 2, 2022, Novavax announced that Swissmedic, the Swiss Agency for Therapeutic Products, had expanded its temporary…
On Aug. 12, 2022, Novavax announced that partner, SK bioscience, had received a Post Approval Change Application approval…
On Jul. 26, 2022, Novavax announced that Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine received expanded manufacturing and marketing approval from…
On Jul. 5, 2022, Novavax announced that the European Commission (EC) had approved the expanded conditional marketing authorization…
On Sept. 16, 2021, Novavax announced its participation in a newly expanded Phase 2 clinical trial called Comparing…
On Jul. 2, 2021, the National Institutes of Health (NIH) announced funding five additional projects to identify ways…
On Jun. 14, 2021, Moderna announced that it had submitted an authorization application to Swissmedic for use of…
On Jun. 10, 2021, Moderna announced that it had requested an emergency use authorization (EUA) for its COVID-19…
On Jun. 12, 2015, the Advisory Committee on Immunization Practices (ACIP) recommended that adolescents and young adults aged…
On Jun. 9, 2005, the U.S. Food and Drug Administration (FDA) announced it had expanded the approved age…
On Aug. 27, 1999, Merck, West Point, Pennsylvania) received approval from the Food and Drug Administration (FDA) of…
On Jul. 2, 1952, Dr. Jonas Salk first innoculated children at the D. T. Watson Home for Crippled…